I.M. Sechenov First Moscow State Medical University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Moscow Russian Federation (1758)

Organization Overview

First Clinical Trial
2002
NCT00715572
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Department of Faculty Therapy No. 1 of the Sechenov University | First Moscow State Medical University n. a. I. M. Sechenov | First MSMU( I.M.Sechenov).The Department of Traumatology,Orthopedics | I.M. Sechenov First Medical State University | I.M. Sechenov First Moscow State Medical University | I.M. Sechenov First Moscow State Medical University (Sechenov University) | Irina Ermolaeva | Sechenov First Moscow Medical University | Sechenov First Moscow State Medical University | Sechenov University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Lung Injury (Phase 4)

Atrial Fibrillation (Phase 4)

Contracture (Phase 2)

Coronary Artery Disease (Phase 4)

Heart Diseases (Phase 4)

Hyperplasia (Phase 4)

Ischemia (Phase 4)

Kidney Diseases (Phase 4)

Lower Urinary Tract Symptoms (Phase 4)

Myocardial Ischemia (Phase 4)

Prostatic Hyperplasia (Phase 4)

Renal Insufficiency, Chronic (Phase 4)

Respiratory Distress Syndrome (Phase 4)

Respiratory Distress Syndrome, Newborn (Phase 4)

Sepsis (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 2)

Torticollis (Phase 2)

Urinary Bladder Neck Obstruction (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 28
  • # of Trial APIs: 45